1. Lam J, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Therapeutics. 2002;8:409-415.
2.
2. Van't Veer C, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor Vl Ia in refractory bleeding disorders. Semin Thromb Hemostas. 2000;26:367-372.
3.
3. Hedner U. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemostas. 2000;26:363-366.
4.
4. Lusher JM, Blatt PM, Penner JA, et al. Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII. Blood. 1983;62:1135-1138.
5.
5. Lusher JM. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol. 1991;28:3-5.
6.
6. Hedner U, Schulman S, Alberta KA, et al. Successful use of rFVIIa in a patient with severe hemophilia A subjected to synovectomy. Lancet. 1988;342(ii):1193-1193.
7.
7. White B, McHale J, Ravi N, et al. Successful use of recombinant factor VIa (Novoseven) in the management of intractable post-surgical intra-abdominal hemorrhage. Br J Haematol. 1999;107:677-678.
8.
8. Bernstein DEJeffers L, Erhardtsen E, et al. Recombinant factor VIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology. 1997;113;1930-1937.
9.
9. Jeffers L, Bernstein DE, Erhardtsen E, et al. The use of recombinant factor VIla in laparoscopy liver biopsy: a pilot trial (abstract). Gastroenterology. 1998;114:L0275-L0275.
10.
10. Erhardtsen R, Nony P, Dechavanne M, et al. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrin. 1998;9:741-748.
11.
11. Hendriks HGD, Meiher K, De Wolf JTM, et al. Reduced transfusion requirements by recombinant factor VIa in orthotopic liver transplantation. Transplantation. 2001;71:402-405.
12.
12. Kalicinski P, Kaminski A, Drewniak H, et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Trans Proc. 1999;31:378-379.
13.
13. Chuansumrit A, Treepongkaruna S, Phuapradit P, et al. Combined fresh frozen plasma with recombinant factor VIa in restoring hemostasis for invasive procedures in children with liver disease. Thromb Haemost. 2001;85:748-749.
14.
14. Poon MC, Demers CJobin F, Wu JWY. Recombinant factor VIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood. 1999;94:3951-3953.
15.
15. Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor VIla in patients with thrombocytopenia. Haemostasis. 1996;26(suppl 1):159-164.
